<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Kazan medical journal</journal-id><journal-title-group><journal-title xml:lang="en">Kazan medical journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Казанский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0368-4814</issn><issn publication-format="electronic">2587-9359</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">677996</article-id><article-id pub-id-type="doi">10.17816/KMJ677996</article-id><article-id pub-id-type="edn">SQMTMG</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Theoretical and clinical medicine</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Теоретическая и клиническая медицина</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Features of type 1 diabetes mellitus in adults depending on the presence of insulin resistance</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности течения сахарного диабета 1-го типа у взрослых пациентов в зависимости от наличия инсулинорезистентности</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>成人患者1型糖尿病病程的特征，取决于胰岛素抵抗的存在</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9841-0611</contrib-id><contrib-id contrib-id-type="spin">2226-4343</contrib-id><name-alternatives><name xml:lang="en"><surname>Malievskaya</surname><given-names>Ramsiya I.</given-names></name><name xml:lang="ru"><surname>Малиевская</surname><given-names>Рамзия Илюсовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Assistant Professor, Depart. of Endocrinology</p></bio><bio xml:lang="ru"><p>ассистент, каф. эндокринологии</p></bio><email>ramsiya1987@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2599-0867</contrib-id><contrib-id contrib-id-type="spin">6813-5061</contrib-id><name-alternatives><name xml:lang="en"><surname>Malievskiy</surname><given-names>Oleg A.</given-names></name><name xml:lang="ru"><surname>Малиевский</surname><given-names>Олег Артурович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>malievsky@list.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Bashkir State Medical University</institution></aff><aff><institution xml:lang="kk"></institution></aff><aff><institution xml:lang="pt"></institution></aff><aff><institution xml:lang="ru">Башкирский государственный медицинский университет</institution></aff><aff><institution xml:lang="zh"></institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Bashkir State Medical University</institution></aff><aff><institution xml:lang="ru">Башкирский государственный медицинский университет</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2025-07-23" publication-format="electronic"><day>23</day><month>07</month><year>2025</year></pub-date><pub-date date-type="pub" iso-8601-date="2025-08-05" publication-format="electronic"><day>05</day><month>08</month><year>2025</year></pub-date><volume>106</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>517</fpage><lpage>525</lpage><history><date date-type="received" iso-8601-date="2025-04-01"><day>01</day><month>04</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-04-23"><day>23</day><month>04</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2025,</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2028-08-05"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://eco-vector.com/for_authors.php#07</ali:license_ref></license></permissions><self-uri xlink:href="https://kazanmedjournal.ru/kazanmedj/article/view/677996">https://kazanmedjournal.ru/kazanmedj/article/view/677996</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND:</bold> Insulin resistance contributes to the clinical course of type 1 diabetes mellitus and increases complication risk in adults.</p> <p><bold>AIM:</bold> This study aimed to assess the clinical characteristics of type 1 diabetes mellitus and prevalence of its complications among men and women with and without insulin resistance.</p> <p><bold>METHODS:</bold> Overall, 317 adults with type 1 diabetes mellitus were examined. The participants were divided into two groups: group 1, 81 patients with insulin resistance; and group 2, 236 patients without insulin resistance. Lipid metabolism parameters and prevalence of macrovascular and microvascular complications were assessed in each group. Anthropometric and laboratory studies included serum creatinine levels with subsequent estimation of glomerular filtration rate, total cholesterol, high- and low-density lipoproteins, triglycerides, and urinary albumin excretion in a random sample. Instrumental examinations involved electroneuromyography, duplex ultrasound scanning of the lower-limb arteries, and fundus examination. Insulin resistance was defined as an estimated insulin sensitivity ≤5.02 in men and ≤5.64 in women. Quantitative data with non-normal distribution were presented as median and 95% confidence interval. For normally distributed variables, the mean and standard deviation were calculated. Categorical data were presented as absolute and relative frequencies. Differences in quantitative parameters were assessed using the Mann–Whitney <italic>U</italic> test and differences in categorical indicators using the <italic>χ</italic><italic><sup>2</sup></italic> test. <italic>P</italic> &lt; 0.05 indicated significant differences.</p> <p><bold>RESULTS:</bold> Insulin resistance prevalence among all patients was 25.6%. Compared to patients without insulin resistance, men and women with insulin resistance more frequently had overweight or obesity (men: 57.1% vs 12.3%, <italic>p</italic> &lt; 0.001; women: 56.4% vs 21.3%, <italic>p</italic> &lt; 0.001), higher total cholesterol levels (men: 5.3 vs 4.6 mmol/L, <italic>p</italic> &lt; 0.001; women: 5.6 vs 4.7 mmol/L, <italic>p</italic> &lt; 0.001), and increased low-density lipoprotein levels (men: 3.4 vs 2.8 mmol/L, <italic>p</italic> &lt; 0.001; women: 3.2 vs 2.7 mmol/L, <italic>p</italic> &lt; 0.001). Men with insulin resistance were more likely to experience hypertension (47.6% vs 14.9%, <italic>p</italic> &lt; 0.001), atherosclerosis (38.1% vs 14.9%, <italic>p</italic> = 0.004), diabetic nephropathy (54.8% vs 18.4%, <italic>p</italic> &lt; 0.001), and retinopathy (81.0% vs 56.1%, <italic>p</italic> = 0.008). Hypertension (46.1% vs 13.9%, <italic>p</italic> &lt; 0.001) and atherosclerosis (30.8% vs 11.5%, <italic>p</italic> = 0.010) were more prevalent in women with insulin resistance.</p> <p><bold>CONCLUSION:</bold> The clinical course of type 1 diabetes mellitus in patients with insulin resistance is characterized by increased cholesterol and low-density lipoprotein levels, higher prevalence of overweight or obesity, and greater incidence of macrovascular complications compared to patients without insulin resistance.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Актуальность.</bold> Наличие инсулинорезистентности вносит определённый вклад в течение сахарного диабета 1-го типа и повышение риска развития его осложнений у взрослых.</p> <p><bold>Цель.</bold> Определить особенности течения сахарного диабета 1-го типа и распространённость его осложнений среди мужчин и женщин с инсулинорезистентностью и без неё.</p> <p><bold>Материал и методы.</bold> Обследовано 317 взрослых пациентов с сахарным диабетом 1-го типа. Все пациенты были разделены на две группы: 1-я группа — 81 пациент с инсулинорезистентностью, 2-я группа — 236 пациентов без инсулинорезистентности. В каждой группе оценивали показатели липидного обмена и распространённость макро- и микрососудистых осложнений. Проведены антропометрическое и лабораторное исследования, включавшие определение уровня креатинина с последующим расчётом скорости клубочковой фильтрации, общего холестерина, липопротеидов высокой и низкой плотности, триглицеридов, уровня альбуминурии в разовой порции мочи. Инструментальные исследования включали электронейромиографию, ультразвуковое дуплексное сканирование артерий нижних конечностей и исследование глазного дна. Инсулинорезистентность устанавливали при расчётной чувствительности к инсулину ≤5,02 у мужчин и ≤5,64 у женщин. Количественные данные при отсутствии нормального распределения представлены в виде медианы и 95% интервала. При нормальном распределении рассчитывали среднее арифметическое и стандартное отклонение. Качественные данные представлены в виде абсолютных и относительных частот. Различия количественных показателей оценивали с использованием U-критерия Манна–Уитни, относительных частот — с применением χ<sup>2</sup>-критерия. Статистически значимыми считали различия при <italic>p</italic> &lt;0,05.</p> <p><bold>Результаты.</bold> Распространённость инсулинорезистентности среди всех обследованных пациентов составила 25,6%. Мужчины и женщины с инсулинорезистентностью по сравнению с пациентами без неё чаще имели избыточную массу тела или ожирение (мужчины: 57,1 и 12,3%, <italic>р</italic> &lt;0,001; женщины: 56,4 и 21,3%, <italic>р</italic> &lt;0,001), более высокие уровни общего холестерина (мужчины: 5,3 и 4,6 ммоль/л, <italic>р</italic> &lt;0,001; женщины: 5,6 и 4,7 ммоль/л, <italic>р</italic> &lt;0,001) и липопротеидов низкой плотности (мужчины: 3,4 и 2,8 ммоль/л, <italic>р</italic> &lt;0,001; женщины: 3,2 и 2,7 ммоль/л, <italic>р</italic> &lt;0,001). У мужчин с инсулинорезистентностью чаще выявляли артериальную гипертензию (47,6 и 14,9%, <italic>р</italic> &lt;0,001), атеросклероз (38,1 и 14,9%, <italic>р</italic>=0,004), диабетическую нефропатию (54,8 и 18,4%, <italic>р</italic> &lt;0,001), ретинопатию (81,0 и 56,1%, <italic>р</italic>=0,008). У женщин с инсулинорезистентностью также чаще дигностировали артериальную гипертензию (46,1 и 13,9%, <italic>р</italic> &lt;0,001) и атеросклероз (30,8 и 11,5%, <italic>р</italic>=0,010).</p> <p><bold>Заключение.</bold> Особенностями течения сахарного диабета 1-го типа у пациентов с инсулинорезистентностью являются более высокие значения холестерина, липопротеидов низкой плотности, большая распространённость избыточной массы тела или ожирения, а также макрососудистых осложнений по сравнению с пациентами без инсулинорезистентности.</p></trans-abstract><trans-abstract xml:lang="zh"><p><bold>研究背景：</bold>胰岛素抵抗的存在有助于1型糖尿病的过程，并增加其在成人中的并发症的风险。</p> <p><bold>目的：</bold>确定1型糖尿病病程的特征及其在有和没有胰岛素抵抗的男性和女性中并发症的患病率。</p> <p><bold>研究对象与方法：</bold>检查了317名1型糖尿病成人患者。所有患者分为两组：组1—81名胰岛素抵抗患者，组2-236名无胰岛素抵抗患者。在每组中，评估脂质代谢的参数以及大血管和微血管并发症的患病率。进行人体测量和实验室研究，包括肌酐水平的测定，随后计算单份尿液中的肾小球滤过率，总胆固醇，高和低密度脂蛋白，甘油三酯和白蛋白尿水平。仪器研究包括电子神经造影，超声双工扫描下肢动脉和眼底检查。建立胰岛素抵抗，估计胰岛素敏感性在男性中&lt;5.02，在女性中&lt;5.64。在没有正态分布的情况下，定量数据以中位数和95％间隔的形式呈现。用正态分布，计算算术平均值和标准偏差。定性数据以绝对频率和相对频率的形式呈现。使用曼-惠特尼 U–检验评估定量指标的差异，使用χ<sup>2</sup>标准评估相对频率。P&lt;0.05处的差异被认为具有统计学意义。</p> <p><bold>结果：</bold>所有检查患者的胰岛素抵抗患病率为25.6％。与没有胰岛素抵抗的患者相比，患有胰岛素抵抗的男性和女性更容易超重或肥胖（男性：57.1和12.3％，<italic>p</italic> &lt;0.001;女性：56.4和21.3％，<italic>p</italic> &lt;0.001），总胆固醇水平较高（男性：3.4和2.8mmol/l，<italic>p</italic> &lt;0.001;女性：3.2和2.7mmol/l，<italic>p</italic> &lt;0.001）。在患有胰岛素抵抗的男性中，高血压（47.6和14.9％，<italic>p</italic> &lt;0.001），动脉粥样硬化（38.1和14.9％，<italic>p</italic>=0.004），糖尿病肾病（54.8和18.4％，<italic>p</italic> &lt;0.001），视网膜病变（81.0和56.1％，<italic>p</italic>=0.008）更常被检 患有胰岛素抵抗的女性也更常被诊断为高血压（46.1和13.9％，<italic>p</italic> &lt;0.001）和动脉粥样硬化（30.8和11.5％，<italic>p</italic>=0.010）。</p> <p><bold>结论：</bold>胰岛素抵抗患者1型糖尿病病程的特征是胆固醇值较高，低密度脂蛋白，超重或肥胖的高患病率，以及与没有胰岛素抵抗的患者相比的大血管并发症。</p></trans-abstract><kwd-group xml:lang="en"><kwd>type 1 diabetes mellitus</kwd><kwd>complications</kwd><kwd>insulin resistance</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>сахарный диабет 1-го типа</kwd><kwd>осложнения</kwd><kwd>инсулинорезистентность</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>1型糖尿病</kwd><kwd>并发症</kwd><kwd>胰岛素抵抗</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Samsonova MD, Trubitsyna NP, Severina AS, Shamkhalova MS. Features of insulin therapy in combination of long-term type 1 diabetes mellitus and metabolic syndrome. Diabetes Mellitus. 2024;27(5):510–515. doi: 10.14341/DM13139 EDN: VUTQMJ</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Helliwell R, Warnes H, Kietsiriroje N, et al. Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: Beyond glycated haemoglobin. Diabet Med. 2021;38(5):e14529. doi: 10.1111/dme.14529 EDN: OPFFMQ</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Lavens A, De Block C, Oriot P, et al. Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study. Diabetologia. 2024;67(12):2678–2690. doi: 10.1007/s00125-024-06273-7 EDN: MKXXKN</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Sun R, Wang J, Li M, et al. Association of Insulin Resistance With Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: Systematic Review and Meta-analysis. Diabetes Care. 2024;47(12):2266–2274. doi: 10.2337/dc24-0475 EDN: DSYFOF</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Šimonienė D, Platūkiene A, Prakapienė E, et al. Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient's Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data. Diabetes Ther. 2020;11(1):161–174. doi: 10.1007/s13300-019-00729-5 EDN: RAASBK</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Petrelli A, Cugnata F, Carnovale D, et al. HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives. Diabetologia. 2024;67(2):290–300. doi: 10.1007/s00125-023-06034-y EDN: ABDABM</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214–E223. doi: 10.1152/ajpendo.1979.237.3.E214</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Certificate of state registration of computer program No. 2025612990 Russian Federation. Evaluation of insulin sensitivity and diagnostics of insulin resistance in adult patients with type 1 diabetes mellitus. Malievskaya RI, Malievskiy OA, Ilyina AA, et al. Claimed: 24.01.2025. Published: 06.02.2025. Applicant: Federal State Budgetary Educational Institution of Higher Education "Bashkir State Medical University" of the Ministry of Health of the Russian Federation. (In Russ.) EDN: GKTPXJ</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Malyugin DA, Volkova SA, Pastukhova LA, Negulyaev AV. Features of clinical course of diabetes mellitus in patients depending on gender. Sovremennye problemy nauki i obrazovaniya. 2024;(2):86. doi: 10.17513/spno.33336 EDN: MMCLME</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Lalanne-Mistrih ML, Bonhoure A, Messier V, et al. Overweight and Obesity in People Living With Type 1 Diabetes: A Cross-Sectional Analysis of the BETTER Registry. Diabetes Metab Res Rev. 2024;40(6):e3837. doi: 10.1002/dmrr.3837 EDN: IJRBDV</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Genua I, Franch-Nadal J, Navas E, et al. Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia. Front Endocrinol. 2022;13:1015614. doi: 10.3389/fendo.2022.1015614 EDN: HFSGKB</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Brown TL, Maahs DM, Bishop FK, et al. Influences of gender on cardiovascular disease risk factors in adolescents with and without type 1 diabetes. Int J Pediatr Endocrinol. 2016;2016:8. doi: 10.1186/s13633-016-0026-6 EDN: JSCZYN</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>de Araujo FM, Comim FV, Lamounier RN, et al. A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients. Diabetol Metab Syndr. 2024;16(1):10. doi: 10.1186/s13098-023-01224-5 EDN: JSRISU</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Giménez-Pérez G, Viñals C, Mata-Cases M, et al. Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia. Cardiovasc Diabetol. 2023;22(1):179. doi: 10.1186/s12933-023-01917-1 EDN: XNOXVG</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Semenova JF, Yushin AY, Korbut AI, Klimontov VV. Glucose Variability in People with Type 1 Diabetes: Associations with Body Weight, Body Composition, and Insulin Sensitivity. Biomedicines. 2024;12(9):2006. doi: 10.3390/biomedicines12092006 EDN: CQUJZF</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Williams KV, Erbey JR, Becker D, et al. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49(4):626–632. doi: 10.2337/diabetes.49.4.626 EDN: DIGTBR</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Nyström T, Holzmann MJ, Eliasson B, et al. Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes. Diabetes Obes Metab. 2018;20(3):556–563. doi: 10.1111/dom.13110</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Lam-Chung CE, Martínez Zavala N, Ibarra-Salce R, et al. Association of estimated glucose disposal rate and chronic diabetic complications in patients with type 1 diabetes. Endocrinol Diabetes Metab. 2021;4(4):e00288. doi: 10.1002/edm2.288 EDN: EODEIV</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Ferreira-Hermosillo A, Ibarra-Salce R, Rodríguez-Malacara J, Molina-Ayala MA. Comparison of indirect markers of insulin resistance in adult patients with Double Diabetes. BMC Endocr Disord. 2020;20(1):87. doi: 10.1186/s12902-020-00570-z EDN: TYBAGR</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Mutter S, Parente EB, Januszewski AS, et al. Insulin sensitivity estimates and their longitudinal association with coronary artery disease in type 1 diabetes. Does it matter? Cardiovasc Diabetol. 2024;23(1):152. doi: 10.1186/s12933-024-02234-x EDN: KHGRTQ</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Dabelea D, D'Agostino RB Jr, Mason CC, et al. Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia. 2011;54(1):78–86. doi: 10.1007/s00125-010-1911-9 EDN: YSMGTN</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Oza C, Khadilkar A, Karguppikar M, et al. Comparison of insulin sensitivity indices for detection of double diabetes in Indian adolescents with type 1 diabetes. J Pediatr Endocrinol Metab. 2022;35(8):1010–1019. doi: 10.1515/jpem-2022-0076 EDN: KADXVR</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Duca LM, Maahs DM, Schauer IE, et al. Development and Validation of a Method to Estimate Insulin Sensitivity in Patients With and Without Type 1 Diabetes. J Clin Endocrinol Metab. 2016;101(2):686–695. doi: 10.1210/jc.2015-3272</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Karamanakos G, Barmpagianni A, Kapelios CJ, et al. The association of insulin resistance measured through the estimated glucose disposal rate with predictors of micro-and macrovascular complications in patients with type 1 diabetes. Prim Care Diabetes. 2022;16(6):837–843. doi: 10.1016/j.pcd.2022.10.003 EDN: YHNLYM</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Pathak V, Mishra I, Baliarsinha AK, Choudhury AK. Prevalence of Insulin Resistance in Type 1 Diabetes Mellitus and Its Correlation with Metabolic Parameters: The Double Trouble. Eurasian J Med. 2022;54(2):107–112. doi: 10.5152/eurasianjmed.2022.21039 EDN: NTXSPZ</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Nishtala R, Kietsiriroje N, Karam M, et al. Estimated glucose disposal rate demographics and clinical characteristics of young adults with type 1 diabetes mellitus: A cross-sectional pilot study. Diab Vasc Dis Res. 2020;17(5):1479164120952321. doi: 10.1177/1479164120952321 EDN: WTFNXN</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Kietsiriroje N, Pearson SM, O'Mahoney LL, et al. Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study. Diab Vasc Dis Res. 2022;19(3):14791641221103217. doi: 10.1177/14791641221103217 EDN: OUQIHN</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 2009;6(6):399–409. doi: 10.1038/nrcardio.2009.55</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Ormazabal V, Nair S, Elfeky O, et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. doi: 10.1186/s12933-018-0762-4 EDN: VJIYQQ</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Linn W, Persson M, Rathsman B, et al. Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational study. Cardiovasc Diabetol. 2023;22(1):61. doi: 10.1186/s12933-023-01791-x EDN: DLEZDE</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Zooravar D, Radkhah H, Amiri BS, Soltani P. Estimated glucose disposal rate and microvascular complications of diabetes mellitus type I: A systematic review and meta-analysis. Diab Vasc Dis Res. 2025;22(2):14791641251324612. doi: 10.1177/14791641251324612 EDN: YMMDWA</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Giandalia A, Giuffrida AE, Gembillo G, et al. Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors. Int J Mol Sci. 2021;22(11):5808. doi: 10.3390/ijms22115808 EDN: RDFUNG</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Piani F, Melena I, Tommerdahl KL, et al. Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications. J Diabetes Complications. 2021;35(4):107841. doi: 10.1016/j.jdiacomp.2020.107841 EDN: NCSLUE</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Pereira-Moreira R, Muscelli E. Effect of Insulin on Proximal Tubules Handling of Glucose: A Systematic Review. J Diabetes Res. 2020;2020:8492467. doi: 10.1155/2020/8492467 EDN: VTRFAS</mixed-citation></ref></ref-list></back></article>
